What triggers blood clots in APS? 

In individuals with antiphospholipid syndrome, the presence of abnormal antibodies creates a constant “pro-thrombotic” state, meaning the blood is biologically primed to clot. However, the antibodies alone do not always cause a clot immediately; instead, a physical blockage is often triggered by a second event that puts additional stress on the vascular system. These triggers can range from acute medical situations, such as surgery or infection, to lifestyle factors and hormonal shifts. In the UK, managing APS involves not only treating the “sticky blood” itself but also identifying and mitigating these specific triggers to prevent clinical complications like deep vein thrombosis or stroke. 

What We’ll Discuss in This Article 

• The “double hit” hypothesis in autoimmune clotting 

• How infections can trigger an active clotting event 

• Risks associated with surgery and physical trauma 

• The impact of pregnancy and hormonal medications 

• Lifestyle factors that lower the clotting threshold 

• The role of inflammatory “flares” in antibody activity 

The Mechanism of Triggers in APS 

Medical researchers often describe the formation of a clot in APS using the “double hit” theory. The “first hit” is the persistent presence of the antiphospholipid antibodies, which bind to the lining of the blood vessels and prime them for a reaction. The “second hit” is an external trigger that provides the final stimulus for a clot to form. This second hit could be something as simple as a minor injury or as complex as a systemic infection. Without the second trigger, many people with APS can have circulating antibodies for long periods without experiencing a symptomatic blood clot. 

Infections as a Primary Trigger 

Infections are a well-recognised trigger for blood clots in people with APS. When the body fights an infection, the immune system becomes highly active, and the levels of inflammation in the blood rise. This inflammatory environment can cause the antiphospholipid antibodies to become more aggressive, leading them to activate platelets and damage the endothelial lining of the blood vessels more rapidly. The NHS notes that because APS is an immune system disorder, any significant illness that affects the immune system can potentially tip the balance toward a clotting event. 

Surgery and Physical Trauma 

Major surgery or severe physical injury acts as a significant trigger because these events naturally stimulate the body’s clotting mechanism to prevent bleeding. For someone with APS, this normal response is often exaggerated. The combination of tissue damage from surgery and the typical period of immobility during recovery creates a high-risk environment for a thrombus to form. UK clinical protocols ensure that patients with known APS receive aggressive preventative care, such as heparin injections, both before and after surgical procedures to counteract these triggers. 

Hormonal Shifts and Pregnancy 

Hormonal changes are powerful triggers for “sticky blood” symptoms. Pregnancy naturally increases the body’s clotting factors, which can amplify the effects of APS antibodies, particularly in the delicate blood vessels of the placenta. Similarly, medications containing oestrogen, such as the combined oral contraceptive pill or hormone replacement therapy, can significantly increase the risk of a clot in women with APS. NICE guidelines advise that women with APS should avoid oestrogen-containing medications and receive specialist monitoring during pregnancy to manage these specific hormonal triggers. 

Lifestyle and Environmental Factors 

Certain lifestyle factors can act as secondary triggers by further damaging the blood vessels or slowing down circulation. Smoking is a major trigger as it causes immediate inflammation of the vessel walls and increases platelet aggregation, directly complementing the harmful effects of APS antibodies. Prolonged immobility, such as during a long-haul flight or after an injury that requires a cast, also acts as a trigger by allowing blood to pool in the veins. Maintaining a healthy weight and staying active are vital for keeping the “second hit” threshold as high as possible. 

Systemic Inflammation and Autoimmune Flares 

Because APS is an autoimmune condition, it is sensitive to the overall level of inflammation in the body. In cases of secondary APS, where the patient also has systemic lupus erythematosus, a “flare-up” of the lupus can act as a direct trigger for a blood clot. During a flare, the immune system is in a state of overactivity, which can increase the concentration and binding strength of the antiphospholipid antibodies. Managing the underlying autoimmune activity is therefore a key part of preventing blood clots in these patients. 

Conclusion 

Blood clots in APS are rarely caused by the antibodies alone and are typically prompted by a “second hit” or trigger. Infections, surgery, hormonal changes, and lifestyle factors all play a role in pushing the pro-thrombotic state into a physical blockage. By identifying these triggers and taking preventative action during high-risk periods, individuals with APS can significantly reduce their clinical risk. Regular consultation with a haematologist or rheumatologist ensures that management plans are adjusted to account for these various triggers. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article examines the clinical triggers for blood clots in antiphospholipid syndrome in alignment with UK medical standards. The content is reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in general medicine and hospital wards where the management of autoimmune clotting risks is a priority. All information is strictly grounded in the clinical guidelines and patient safety protocols provided by the NHS and NICE.